CEACAM-5/CD66e (501-685), His, Human
CEACAM-5/CD66e (501-685), His, Human

Immobilized CEACAM-5/CD66e (501-685), His, Human, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-CEACAM5 Antibody, hFc Tag with the EC50 of 5.5 ng/ml determined by ELISA.

CEACAM-5/CD66e (501-685), His, Human

The purity of CEACAM-5/CD66e (501-685), His, Human is greater than 95% as determined by SEC-HPLC.

CEACAM-5/CD66e (501-685), His, Human

CEACAM-5/CD66e (501-685), His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

CEACAM-5/CD66e (501-685), His, Human

Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) was identified as a metastatic driver. CEACAM5 overproduction enriched for an epithelial gene expression pattern and facilitated tumor outgrowth at metastatic sites. Tissues from patients with metastatic breast cancer confirmed elevated levels of CEACAM5 in lung metastases relative to breast tumors, and an inverse correlation between CEACAM5 and the mesenchymal marker vimentin was demonstrated.
Z03832
¥83,944.00

Ask us a question
Product Introduction
Species Human
Protein Construction
CEACAM-5/CD66e (Pro501-Ala685)
Accession # P06731-1		 His
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Immobilized CEACAM-5/CD66e (501-685), His, Human (Cat.No.: Z03832) at 2 μg/ml (100μl/Well) on the plate can bind Anti-CEACAM5 Antibody.
Expression System HEK293
Theoretical Molecular Weight 20.89 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4.
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • CEACAM-5/CD66e (501-685), His, Human
    • CEACAM-5/CD66e (501-685), His, Human

    Immobilized CEACAM-5/CD66e (501-685), His, Human, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-CEACAM5 Antibody, hFc Tag with the EC50 of 5.5 ng/ml determined by ELISA.

  • CEACAM-5/CD66e (501-685), His, Human
    • CEACAM-5/CD66e (501-685), His, Human

    The purity of CEACAM-5/CD66e (501-685), His, Human is greater than 95% as determined by SEC-HPLC.

  • CEACAM-5/CD66e (501-685), His, Human
    • CEACAM-5/CD66e (501-685), His, Human

    CEACAM-5/CD66e (501-685), His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background CEACAM5 (Carcinoembryonic antigen-related cell adhesion molecule 5), is also known as CD66e (Cluster of Differentiation 66e). The overproduction of CEACAM5 could enrich for an epithelial gene expression pattern and facilitate tumor outgrowth at metastatic sites. CEACAM5 is often used as a synonym for many types of malignancies, such as colorectal cancer and non-small-cell lung cancer.
Synonyms CEACAM-5; CD66e; CEA; Meconium antigen 100; Carcinoembryonic; CEACD66e; DKFZp781M2392

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.